Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-operative NSAIDs in Breast Cancer
NCT02141139Phase 3Unknown
- Sponsor
- Samsung Medical Center
- Start
- Sep 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketorolac and ibuprofen in breast cancer (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Disease Free Survival at 5 years. Status: unknown.
02
Drugs
ketorolacibuprofen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02141139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141139.